Copyright
©The Author(s) 2023.
World J Clin Cases. Nov 26, 2023; 11(33): 8030-8037
Published online Nov 26, 2023. doi: 10.12998/wjcc.v11.i33.8030
Published online Nov 26, 2023. doi: 10.12998/wjcc.v11.i33.8030
Parameter | Patient’s value | Reference value |
White blood cell count (109/L) | 3.93 | 3.50–9.50 |
C-reactive protein (mg/L) | 0.23 | 0–6 |
Neutrophils (%) | 36.00 | 40–75 |
Lymphocytes (%) | 55.70 | 20–50 |
Monocytes (%) | 5.20 | 3–10 |
Hemoglobin (g/L) | 109.00 | 115.0–150.0 |
Platelet count (109/L) | 172 | 125–350 |
Activated thromboplastin time (s) | 13.50 | 9.4-12.5 |
Activated partial thromboplastin time (s) | 11.0 | 11–14 |
Albumin (g/L) | 38.6 | 40.0–55.0 |
Total protein (g/L) | 62.8 | 65.0–85.0 |
Total bilirubin (μmol/L) | 21.0 | 0.0–21.0 |
Aspartate aminotransferase (U/L) | 15.1 | 13.0–35.0 |
Alanine aminotransferase (U/L) | 12.4 | 7.0–40.0 |
Blood creatinine (μmol/L) | 54.5 | 41.0–81.0 |
Parameter | Patient’s value | Reference value |
Carcinoembryonic antigen (ng/mL) | 1.36 | 0–5.0 |
Alpha-fetoprotein (ng/mL) | 1.71 | < 9.01 |
CA-199 (U/mL) | 3.40 | 0–25 |
β-human chorionic gonadotropin (mIU/mL) | 0.24 | 0–35 |
CA-125 (U/mL) | 15.17 | 0–5 |
CA-15-3 (U/mL) | 3.10 | 0–14 |
CA-50 (U/mL) | 3.91 | < 25 |
CA-72-4 (U/mL) | 4.02 | 0–10 |
CA-24-2 (U/mL) | 4.27 | < 25 |
Squamous cell carcinoma-associated antigen (ng/mL) | 0.78 | 0–1.5 |
Cytokeratin 19 fragment (ng/mL) | 1.59 | < 3.3 |
Neuron specific enolase (ng/mL) | 9.93 | 0–20 |
Parameter | Patient’s value | Reference value |
Color | Yellow | |
Solidification | No solidification | |
Pellucidity | Slightly turbid | |
Proportion | 1.010 | Leakage fluid < 1.015 Exudate > 1.018 |
Rivalta test | + | Leakage fluid: - Exudate: + |
White blood cell count (109/L) | 0.04 | Leakage fluid < 0.1 Exudate > 0.5 |
Red blood cell count (109/L) | 0.40 | 0 |
Other | Cholesterol crystals detected |
Parameter | Patient’s value |
TG (mmol/L) | 0.12 |
GLU (mmol/L) | 0.37 |
CH (mmol/L) | 0.67 |
AMY (U/L) | 55 |
ADA (U/L) | 25.6 |
LDH (U/L) | 58.6 |
ACE (U/L) | 6.1 |
Total protein (g/L) | 66.4 |
Albumin (g/L) | 42.4 |
Parameter | Patient’s value | Reference value |
Carcinoembryonic antigen (ng/mL) | 0.43 | 0–5.0 |
Alpha-fetoprotein (ng/mL) | 0.72 | < 9.01 |
- Citation: Li S, Tang J, Ni DS, Xia AD, Chen GL. Giant complex hepatic cyst causing pseudocystitis: A case report. World J Clin Cases 2023; 11(33): 8030-8037
- URL: https://www.wjgnet.com/2307-8960/full/v11/i33/8030.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i33.8030